Catalyst Wire Dossier Catalyst Wire Dossier

Ombitasvir (ABT-267)

Ombitasvir · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ombitasvir (ABT-267), covering 2014-02-19 to 2014-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability of ABT-450 and ABT-267 With Ritonavir [Phase 1]

See pricing